Previous studies have demonstrated that down–regulation of clusterin in rheumatoid arthritis (RA), is associated with synovial fibroblast resistance to FasL-mediated apoptosis46 and that transgenic overexpression of clusterin in RA synovial fibroblasts promoted apoptosis17. The gene discussed is CLU; the disease is rheumatoid arthritis.